Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

SLSSLS
5 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in SELLAS LIFE SCIENCES GROUP I

Yes. BNP Paribas Financial Markets holds 1,072,022 shares of SLS (Sellas Life Sciences Group), worth $15.8M, as of its Q2 2026 13F filing. It increased the position from 47,016 shares in Q1 2026. BNP Paribas Financial Markets has held SLS since Q2 2025, across 5 quarterly 13F filings.

Current Value

$15.8M

Current Shares

1.1M

Total Value Change

+$15.8M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+2180.1%
$15.8M0.0%$14.76
45
2026-Q1
Increased
47,016
+75.2%
$198,8780.0%$4.23
34
2025-Q4
Increased
26,838
+36.1%
$101,1790.0%$3.77
19
2025-Q3
Increased
19,724
+89.2%
$31,7560.0%$1.61
21
2025-Q2
New
10,425
-
$22,8310.0%$2.19
29

Other major holders of SLS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used